title: Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model.
abstract: Progressive saphenous vein graft (SVG) narrowing and occlusion remains a major limitation of coronary artery bypass grafting and is an important target for gene therapy. Ex vivo adenoviral gene transfer of tissue inhibitor of metalloproteinase 3 (TIMP-3) reduces adverse SVG remodelling postarterialization, but concerns remain over the use of viral vectors in patients. Ultrasound exposure (USE) in the presence of echocontrast microbubbles (ECM) substantially enhances nonviral gene delivery. We investigated the effects of ultrasound-enhanced gene delivery (UEGD) of TIMP-3 plasmid on vascular remodelling in porcine SVG. Maximal luciferase activity (3000-fold versus naked plasmid alone) and TIMP-3 transgene expression in porcine vascular smooth muscle cells in vitro was achieved using USE at 1 MHz, 1.8 mechanical index (MI), 6% duty cycle (DC) in the presence of 50% (v/v) BR14 ECM (Bracco). These conditions were therefore utilized for subsequent studies in vivo. Yorkshire White pigs received carotid interposition SVG that were untransfected or had undergone ex vivo UEGD of lacZ (control) or TIMP-3 plasmids. At 28 d postgrafting, lumen and total vessel area were significantly greater in the TIMP-3 group (10.1+/-1.2 and 25.5+/-2.2 mm2, respectively) compared to untransfected (6.34+/-0.5 and 20.8+/-1.9 mm2) or lacZ-transfected (6.1+/-0.7 and 19.7+/-1.2 mm2) controls (P<0.01). These data indicate that nonviral TIMP-3 plasmid delivery by USE achieves significant biological effects in a clinically relevant model of SV grafting, and is the first study to demonstrate the potential for therapeutic UEGD to prevent SVG failure.
authors.affiliation: Cardiovascular Research Unit, Division of Clinical Sciences (North), Clinical Sciences Centre, University of Sheffield, Northern General Hospital, Sheffield, UK.
authors.forename: E F
authors.initials: EF
authors.lastname: Akowuah
authors.forename: C
authors.initials: C
authors.lastname: Gray
authors.forename: A
authors.initials: A
authors.lastname: Lawrie
authors.forename: P J
authors.initials: PJ
authors.lastname: Sheridan
authors.forename: C-H
authors.initials: CH
authors.lastname: Su
authors.forename: T
authors.initials: T
authors.lastname: Bettinger
authors.forename: A F
authors.initials: AF
authors.lastname: Brisken
authors.forename: J
authors.initials: J
authors.lastname: Gunn
authors.forename: D C
authors.initials: DC
authors.lastname: Crossman
authors.forename: S E
authors.initials: SE
authors.lastname: Francis
authors.forename: A H
authors.initials: AH
authors.lastname: Baker
authors.forename: C M
authors.initials: CM
authors.lastname: Newman
mesh_terms: D000818:Animals; D003287:Contrast Media; D001026:Coronary Artery Bypass; D006083:Graft Occlusion, Vascular / Q000473:pathology / Q000517:prevention & control; D010957:Plasmids; D012501:Saphenous Vein / Q000473:pathology / Q000637:transplantation*; D013552:Swine; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000235:genetics* / Q000378:metabolism; D014162:Transfection / Q000379:methods*; D014465:Ultrasonics
chemical_list: D003287:Contrast Media; D019717:Tissue Inhibitor of Metalloproteinase-3